Pancreatic Disease Centre, Department of Gastroenterology, First Affiliated Hospital of Nanchang University, Nanchang, China.
Pancreatic Disease Centre, Department of Gastroenterology, First Affiliated Hospital of Nanchang University, Nanchang, China.
HPB (Oxford). 2021 Dec;23(12):1856-1864. doi: 10.1016/j.hpb.2021.04.024. Epub 2021 May 5.
This study investigated risk factors for bleeding in patients with acute necrotizing pancreatitis (ANP) undergoing endoscopic necrosectomy (EN) and the effect of endoscopic haemostasis.
145 patients with ANP who underwent EN were recruited from January 2014 to December 2018. Patients with and without bleeding were allocated to the bleeding and nonbleeding groups, respectively. Multivariable logistic regression models were used to assess independent risk factors for bleeding.
39 patients (26.9%) experienced bleeding. The body mass index and culture-confirmed infectious pancreatic necrosis (IPN), renal failure and continuous renal replacement therapy rates were significantly higher in the bleeding group (all P < 0.01). In addition, the number of debridement procedures was significantly higher in the bleeding group (P = 0.004), accompanied by a higher mortality rate and greater hospitalization costs (all P < 0.05). Most cases of bleeding during EN were successfully stopped by endoscopic haemostasis (94.1%), but this was difficult to achieve after EN. Multivariate analysis revealed that renal failure (odds ratio [OR]: 3.77, P = 0.02), culture-confirmed IPN (OR: 3.19, P = 0.02), and ≥3 debridement procedures (OR: 12.92, P = 0.001) were associated with an increased bleeding risk.
Renal failure, culture-confirmed IPN, and multiple debridement procedures were independent risk factors for bleeding in patients with ANP who underwent EN.
本研究旨在探讨接受内镜坏死组织清除术(EN)的急性坏死性胰腺炎(ANP)患者出血的风险因素,以及内镜止血的效果。
2014 年 1 月至 2018 年 12 月,共招募了 145 例接受 EN 的 ANP 患者。根据是否发生出血,将患者分为出血组和非出血组。采用多变量逻辑回归模型评估出血的独立危险因素。
39 例(26.9%)患者发生出血。出血组的体质指数和培养证实的感染性胰腺坏死(IPN)、肾衰竭和持续肾脏替代治疗的发生率明显更高(均 P<0.01)。此外,出血组的清创次数明显更多(P=0.004),死亡率和住院费用也更高(均 P<0.05)。EN 期间大多数出血病例通过内镜止血成功停止(94.1%),但 EN 后难以止血。多变量分析显示,肾衰竭(优势比[OR]:3.77,P=0.02)、培养证实的 IPN(OR:3.19,P=0.02)和≥3 次清创术(OR:12.92,P=0.001)与出血风险增加相关。
肾衰竭、培养证实的 IPN 和多次清创术是接受 EN 的 ANP 患者出血的独立危险因素。